In 2009, Zamboni et al. coined the term "chronic cerebrospinal venous insufficiency" (CCSVI). On the basis of transcranial and extra-cranial colour-coded Doppler ultrasonography, they operationally defined CCSVI as occurring when at least two out of five "abnormalities" were present. They claimed to find CCSVI in 100 % of 109 individuals with multiple sclerosis (MS) and in none of 177 healthy controls. Zamboni's group subsequently reported an uncontrolled treatment trial of cerebral venoplasty, which was termed the "liberation procedure" and claimed that the procedure benefited people with MS. The Zamboni reports were received with considerable skepticism, regarding both their biological plausibility and the claims of 100 % sensitivity, specificity, positive predictive value and negative predictive value. No investigators have subsequently been able to replicate the Zamboni observations. Although some additional reports have indicated finding venous abnormalities in more MS patients than in other groups, most have either found no association of CCSVI with MS, or else have 
Beginning with the publication of a paper by Paolo Zamboni in
2009
1 that claimed an association between a number of cerebral venous 'abnormalities' and multiple sclerosis (MS), the international MS community has been embroiled in a debate, unprecedented in scope and controversy. The original Zamboni paper defined 'chronic cerebrospinal venous insufficiency' (CCSVI) as the presence of two or more of five criteria they described as abnormalities of the venous system draining the brain and spinal cord based exclusively on examination by transcranial and extracranial colour-coded Doppler examination.
The initial Zamboni study evaluated 109 MS patients and 177 healthy controls and the investigators reported the occurrence of CCSVI in every MS patient and in none of the controls. In other words, the authors claimed that the presence of CCSVI was 100 % sensitive, 100 % specific, and had 100 % positive predictive value and 100 % negative predictive value for MS. This paper was followed later in 2009 by a report by the Zamboni group of an uncontrolled treatment trial of cerebral venoplasty in 65 patients with MS. 2 The authors observed that patients receiving the intervention, which was termed 'liberation procedure', were significantly more likely to be relapse-free post-operatively than pre-operatively and to have fewer gadolinium enhanced lesions post-operatively. In addition the authors noted that, based on the multiple sclerosis functional composite (MSFC) score, the cohort improved at one year. The findings of the Zamboni group were subsequently catapulted to international attention by a series of reports in the mainstream media, especially in Canada. Understandably excited by the undeniable appeal of the prospect of obtaining dramatic improvement or even a 'cure' of their MS, patients around the world began to seek the procedure and to demand it where it was not readily available, again particularly in Canada. The controversy and dialogue spread rapidly through the social media, with numerous reports of subjective symptomatic improvement by individuals with MS who had undergone the procedure.
Skepticism in the Scientific Community
The initial Zamboni reports were met with considerable skepticism by most of the MS scientific and professional community. Like any 
No Replication of Zamboni Results
What Sundström et al. 5 and Wattjes et al. 6 failed to find any support for the Zamboni hypothesis. In a subsequent study using magnetic resonance venography Doepp et al., also failed to substantiate CCSVI. 7 Nonetheless, a recent meta-analysis by Laupacis et al. 8 found that the published data did suggest the possibility of an association between CCSVI and MS. However, the authors emphasised that no definitive conclusions could be drawn because the cited studies 
Significance of Canadian Institutes of Health Research Announcement in Public Domain
One thing is certain, however. That is the clear recognition that 
CCVI in MS -A Medical, Sociological and Media Controversy
As the CCSVI controversy continues, hopefully to be resolved with the time-tested methods of appropriate scientific investigation, how should physicians respond to patient inquiries and sometimes to their demands to undergo venoplasty? Physicians should always be respectful of patient's views, but should not be reluctant to offer their professional opinion based on a thoughtful consideration of available evidence. This can dovetail with a discussion that emphasises the importance of proper scientific research. The physician must always respect patient autonomy, avoid acting judgmentally and emphasise that he or she will always be available to offer the patient continued care and support. However the CCSVI story plays out, as it inevitably will, scientists, physicians and patients should seek to benefit from what it teaches us. These lessons include recognising the importance of empathy for those affected by serious illness, understanding the enormous power and speed of the social media, and comprehending the delicate balance between patient desire and the need for scientific rigour that will enable the utilisation of relatively scarce financial resources in a way that maximises patient safety while providing the best opportunity to understand and ultimately treat human disease. n Editorial
